证券代码：301101 证券简称：明月镜片 公告编号：2025-017 明月镜片股份有限公司 关于注销部分募集资金专项账户的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、募集资金基本情况 经中国证券监督管理委员会《关于同意明月镜片股份有限公司首次公开发行 股票注册的批复》（证监许可〔2021〕3473 号）同意注册，公司获准首次公开发 行人民币普通股（A 股）股票 3,358.54 万股，每股面值 1 元，每股发行价格为 人民币 26.91 元，募集资金总额为人民币 903,783,114.00 元，扣除各类发行费 用后实际募集资金净额为人民币 792,923,877.64 元。上述募集资金到位情况经 立信会计师事务所（特殊普通合伙）进行了审验，并于 2021 年 12 月 13 日出具 了"信会师报字[2021]第 ZA15935 号"《验资报告》。 公司已将上述募集资金存放于募集资金专项账户，并与保荐机构、存放募集 资金的商业银行签署了《募集资金监管协议》。 二、募集资金存放与管理情况 为了规范募集资金的管理和使用，保护投资者权益，公司已按照《 ...

Core Viewpoint - The announcement reveals plans for significant share reductions by major shareholders and executives of Mingyue Lens, indicating potential changes in ownership dynamics and investor sentiment towards the company [1][2][3] Group 1: Shareholder Reductions - The controlling shareholder, Shanghai Mingyue Industrial Co., Ltd., and its actual controllers plan to reduce their holdings by up to 6,000,000 shares, representing 2.9891% of the total share capital excluding repurchased shares, within a three-month period from June 11 to September 10, 2025 [1] - The board member and deputy general manager, Zeng Zhe, intends to reduce his holdings by up to 800,000 shares, which is 24.4312% of his total shares, equating to 0.3985% of the total share capital excluding repurchased shares [2] - Shareholder Nuo Wei Qi plans to reduce his holdings by up to 3,000,000 shares, representing 1.4945% of the total share capital excluding repurchased shares [2] Group 2: Shareholder Relationships - The actual controllers, Xie Gongwan, Xie Gongxing, and Zeng Shaohua, are related, with Xie Gongwan and Xie Gongxing being brothers and Zeng Shaohua being Xie Gongwan's sister's spouse; they collectively hold 100% of Shanghai Mingyue [3] - The relationship among the shareholders indicates a coordinated approach to share reduction, as they are considered acting in concert [3] Group 3: Company Background - Mingyue Lens was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on December 16, 2021, with an initial public offering of 33.5854 million shares at a price of 26.91 yuan per share [3] - The total funds raised from the IPO amounted to 904 million yuan, with a net amount of 793 million yuan after deducting issuance costs, exceeding the original plan by 225 million yuan [3] - The funds raised are intended for various projects, including high-end resin lens expansion, conventional resin lens expansion and technology upgrades, research center construction, and marketing network development [3]

Group 1 - The controlling shareholder of Mingyue Optical (301101.SZ) plans to reduce its stake by up to 6,000,000 shares within three months from June 11, 2025, to September 10, 2025, which represents approximately 2.9891% of the total share capital after excluding shares in the company's repurchase account [1] - The reduction will occur through centralized bidding and block trading, with a maximum of 1% of the total share capital being sold via centralized bidding and up to 2% through block trading [1] - The company's Vice President and Board Secretary, Zeng Zhe, intends to reduce his holdings by up to 800,000 shares, accounting for 24.4312% of his total holdings, which is approximately 0.3985% of the total share capital after excluding repurchased shares [1] Group 2 - Shareholder Nuo Wei Qi plans to reduce its stake by up to 3,000,000 shares within the same three-month period, representing about 1.4945% of the total share capital after excluding shares in the company's repurchase account [2] - Similar to the previous shareholder, the reduction will also be executed through centralized bidding and block trading, with a maximum of 1% of the total share capital being sold via centralized bidding and up to 2% through block trading [2]

Core Viewpoint - The announcement details the planned share reduction by major shareholders of Mingyue Lens Co., Ltd., including the controlling shareholder Shanghai Mingyue Industrial Co., Ltd. and other significant stakeholders, indicating a total reduction of up to 6,000,000 shares over a specified period [1][2][3]. Shareholder Reduction Plan - The controlling shareholder Shanghai Mingyue Industrial and its associated parties plan to reduce their holdings by a maximum of 6,000,000 shares, which represents approximately 2.9891% of the total share capital after excluding shares in the company's repurchase account [1][2]. - The reduction will occur between June 11, 2025, and September 10, 2025, through both centralized bidding and block trading methods [1][3]. - The maximum reduction through centralized bidding will not exceed 1% of the total share capital after excluding repurchased shares, while the block trading method will not exceed 2% [1][4]. Shareholder Details - Major shareholders include: - Shanghai Mingyue Industrial: 111,004,500 shares (55.2997%) - Xie Gongwan: 4,933,500 shares (2.4577%) - Xie Gongxing: 4,933,500 shares (2.4577%) - Zeng Shaohua: 2,467,500 shares (1.2292%) - Danyang Zhiming: 3,510,000 shares (1.7486%) - Total for these shareholders: 126,849,000 shares (63.1930%) [2][3]. Compliance and Commitments - The shareholders have committed to ensuring that the information provided is accurate and complete, with no misleading statements or significant omissions [1]. - The planned share reduction aligns with previous commitments made by the shareholders regarding their shareholding intentions and restrictions [4][5].

证券代码：301101 证券简称：明月镜片 公告编号：2025-015 明月镜片股份有限公司 关于实际控制人及其一致行动人、董事兼高级管理人员、 持股 5%以上股东减持股份的预披露公告 明月镜片股份有限公司（以下简称"公司"、"本公司"或"明月镜片"） 控股股东上海明月实业有限公司（以下简称"上海实业"）、实际控制人谢公 晚先生、谢公兴先生、曾少华先生及其一致行动人丹阳市志明企业管理中心（有 限合伙）（以下简称"丹阳志明"）、董事兼高级管理人员曾哲先生、持股 5% 以上股东上海诺伟其定位投资管理有限公司－宁波梅山保税港区诺伟其定位 创业投资合伙企业（有限合伙）（以下简称"诺伟其"）保证向本公司提供的 信息内容真实、准确和完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一 致。 特别提示： 1、合计持有公司 126,849,000 股（占剔除公司回购专用账户股份数量后总 股本的 63.1930%）的控股股东上海实业、实际控制人谢公晚先生、谢公兴先生、 曾少华先生及其一致行动人丹阳志明拟于本公告披露之日起 15 个交易日后的 3 个月内（即 2025 年 6 ...

Core Points - The company announced a cash dividend distribution of RMB 5.00 per 10 shares (including tax) to all shareholders, based on a total share capital of 200,732,618 shares after excluding repurchased shares [1][2] - The total cash dividend amount is calculated to be RMB 100,366,309, which translates to approximately RMB 0.4981 per share [1][2] - The record date for the dividend distribution is set for May 22, 2025, and the ex-dividend date is May 23, 2025 [3] Dividend Distribution Details - The dividend distribution plan was approved at the annual general meeting held on May 13, 2025, with a total share capital of 201,512,100 shares, of which 779,482 shares are held in the company's repurchase account and do not participate in the distribution [2] - The cash dividend will be directly credited to shareholders' accounts through their custodial securities companies on the ex-dividend date [3][4] - Different tax rates apply for various categories of shareholders, with specific provisions for Hong Kong investors and domestic investors holding different types of shares [2][4] Shareholder Commitments - The company has commitments from certain shareholders regarding the minimum selling price of their shares, which will be adjusted based on the dividend distribution [4] - The initial public offering price was RMB 26.91 per share, and this price will be adjusted to RMB 16.59 per share following the current dividend distribution [4]

证券代码：301101 证券简称：明月镜片 公告编号：2025-016 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、明月镜片股份有限公司（以下简称"公司"）通过回购专户持有的公司 股份 779,482 股，不参与本次权益分派。因此，本次权益分派以总股本扣除公司 回购专户中已回购股份后的总股本 200,732,618 股为基数，向全体股东每 10 股 派发现金股利人民币 5.00 元（含税）。 2、本次权益分派实施后，按公司总股本折算每股现金分红比例计算如下： 本次实际现金分红总额=（股权登记日的总股本-回购专户中的股份）×每股 分红金额=200,732,618×5÷10=100,366,309 元； 公司总股本折算每股现金红利=本次实际现金分红总额÷股权登记日的总股 本=100,366,309÷201,512,100=0.4980659 元/股，每 10 股现金红利为 4.980659 元； 3、2024 年度权益分派实施后的除权（息）价按照上述原则和方式执行，即 本次权益分派实施后的除权（息）参考价：除权（息）参考价格=（股权登记日 收盘 ...

Core Viewpoint - The company reported a mixed performance in 2024, with a notable increase in revenue from its key products despite challenges in overseas business and raw material procurement [2][8]. Financial Performance - The total revenue for 2024 was 770 million yuan, representing a year-on-year growth of 2.88% [8]. - The net profit attributable to shareholders was 177 million yuan, showing a year-on-year increase of 12.21% [8]. - The gross profit margin reached 58.56%, an increase of 0.98 percentage points compared to the previous year [8]. Product Performance - The lens business revenue grew by 8.72% compared to 2023, indicating the effectiveness of the focus on major products [2]. - The PMC Ultra Bright series saw a significant revenue increase of 45.6% year-on-year, with growth trends continuing into Q1 2025 [2][11]. - The "Easy Control" series generated sales of 50.13 million yuan in Q1 2025, reflecting a year-on-year growth of 22.1% [9]. Market Strategy - The company has permanently exited the price war and shifted focus to high-end product development and brand building since 2019 [8]. - The company aims to expand its brand presence internationally, particularly in markets like Japan, Southeast Asia, and parts of Europe [12]. Industry Trends - The market for defocus lenses is experiencing rapid growth, with many companies entering this segment [9]. - Despite price wars initiated by some foreign brands, the negative impact is gradually diminishing [9]. Sales Channels - The sales strategy includes a mix of direct sales and distribution through 66 partners, including medical channels [11]. - The company has only one model experience store to assist clients in improving transaction efficiency rather than competing with them [11].

证券代码：301101 证券简称：明月镜片 公告编号：2025-014 明月镜片股份有限公司 2024 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示 一、 会议召开情况 6、 本次会议的召集、召开符合有关法律、行政法规、部门规章、规范性文 件和公司章程等的规定。 二、 会议出席情况 （一）股东出席的总体情况 出席本次股东大会现场会议和网络投票表决的股东及股东代理人共 141 人， 1、 本次股东大会不存在否决议案的情形。 2、 本次股东大会不涉及变更以往股东大会已通过的决议。 1、 召开时间： （1） 会议召开时间：2025 年 5 月 13 日（星期二）14:30。 （2） 网络投票时间：2025 年 5 月 13 日。 其中通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 5 月 13 日 9:15—9:25，9:30—11:30 和 13:00—15:00；互联网投 票系统投票的时间为 2025 年 5 月 13 日 9:15—15:00 期间的任意时 间。 2、 召开地点：上海市普陀区岚皋路 567 ...

上海市广发律师事务所 关于明月镜片股份有限公司 2024 年年度股东大会的 法律意见书 电话：021-58358013 | 传真：021-58358012 网址：http://www.gffirm.com | 电子信箱：gf@gffirm.com 办公地址：上海市浦东新区南泉北路 429 号泰康大厦 26 楼 | 邮政编码：200120 上海市广发律师事务所 关于明月镜片股份有限公司 明月镜片股份有限公司（以下简称"公司"）2024 年年度股东大会于 2025 年 5 月 13 日在上海市普陀区岚皋路 567 号 3 楼会议室召开。上海市广发律师事务 所经公司聘请，委派成赟律师、陈雨兰律师出席现场会议，根据《中华人民共和 国公司法》（以下简称"《公司法》"）、《上市公司股东会规则》（以下简称"《股东 会规则》"）等法律法规、其他规范性文件以及《明月镜片股份有限公司章程》（以 下简称"《公司章程》"）的规定，就本次股东大会的召集和召开程序、召集人及 出席会议人员的资格、会议议案、表决方式和表决程序、表决结果和会议决议等 出具本法律意见书。 为出具本法律意见书，本所律师对本次股东大会所涉及的有关事项进行了审 查， ...